In this post in PSI’s “Healthy Lives” blog, Benoy Peter, senior manager for knowledge management at Project Connect in India, reports that the government of India will cover HIV care under insurance in the country beginning in October 2012. Peter recounts the advocacy efforts that went into convincing the Indian government to make the change and writes, “We are excited about the maiden policy change facilitated by PSI/India. Much deserved credit goes to [the National AIDS Control Organisation (NACO)], USAID, our partners and a few activists who enlightened by our conference did their parallel lobbying” (2/22).
Access to Health Services
In this post in the Results for Development Institute’s “Center for Global Health R&D Policy Assessment” blog, Project Director Jean Arkedis and Program Associate Edith Han interview Megumi Gordon, deputy director for malaria at the Clinton Health Access Initiative (CHAI), “to take an exclusive look into the [Affordable Medicines Facility for Malaria (AMFm)] and its innovative mechanism to increase access to antimalarials.” Megumi discusses “AMFm’s current status, early lessons, and the latest in the ongoing — and sometimes contentious — debate about whether to subsidize [artemisinin-based combination therapies (ACTs)] in the private sector” (2/22).
Trade Officials, Public Health Advocates To Discuss Intellectual Property, Access To Medicines At Open Hearing
“The U.S. government has an unfortunate history of pressuring low- and middle-income countries to observe strong intellectual property protection on medicines …, block[ing] access to generics in countries unable to afford expensive brand name drugs sold by American drug companies,” a post on infojustice.org reports. “[Thursday], trade officials will hear from public…
“More than seven months overdue, the Global Fund to Fight AIDS, Tuberculosis and Malaria grant will finally be released to key South African AIDS organizations that have been struggling to survive,” PlusNews writes, adding, “Some were on the verge of shutting down.” According to the news service, “The Global Fund released US$7,106,426.91 to the South African National Treasury on February 6, the same day seven of the grant’s sub-recipients delivered an open letter to Minister of Health Aaron Motsoaledi, pleading for intervention.”
This post in the UHC Forward blog describes the second meeting of the Universal Health Coverage Roundtable Series, “Toward Sustainable Universal Health Coverage,” which was hosted by the Council on Foreign Relations in New York City on February 9. The panelists “examined the possibilities, challenges, and paths toward achieving Universal Health Coverage in different resource settings by exploring the methods for expanding and supporting coverage worldwide” and discussed issues such as how to define UHC, the importance of quality in health care, improving cost-effectiveness, and how to increase utilization of existing services, according to the blog (Wellington, 2/20).
Approximately 85,000 HIV-positive people in Burma, also known as Myanmar, are in need of antiretroviral treatment (ART) and cannot access it “due to a lack of funding, despite renewed international engagement with the government amid a wave of political reform, according to a report released Wednesday” by the medical aid group Medecins Sans Frontieres (MSF), the Associated Press/CBS News reports (2/22). “At the launch of a new report called ‘Lives in the Balance,’ MSF said that only a quarter of the estimated 120,000 people living with HIV and AIDS were receiving treatment, and that it was turning people away from its clinics,” BBC News writes. While plans were made last year among MSF and its partners to scale up treatment for HIV and tuberculosis (TB), “those proposals were shelved after the Global Fund” to Fight AIDS, Tuberculosis and Malaria cancelled its Round 11 grants, according to the news agency. “The money was expected to provide HIV drugs for 46,500 people in Myanmar, along with treatment for another 10,000 people sicken[ed] by drug-resistant tuberculosis in the country, [the report] said,” BBC writes (Fisher, 2/22).
CBS News examines the fight against tuberculosis (TB) in South Korea, which “has the highest incidence rate of tuberculosis among the world’s wealthiest countries, nations [that] belong to the 34-member Organization for Economic Cooperation and Development (OECD).” The news service continues, “In 2010, South Korea’s incidence rate of tuberculosis was 97 out of 100,000, according to the World Health Organization (WHO), while the mortality rate of TB was 5.4 out of 100,000. (In the U.S., the incidence rate was 4.1 and the mortality rate was 0.18 during the same time period.)”
“While international attention focuses on Burma, [also known as Myanmar,] a health crisis in the country looms large,” Joe Billiveau, operations manager of Medecins Sans Frontieres’ (MSF) operational center in Amsterdam, writes in this opinion piece in Bangkok’s Nation. He continues, “An estimated 85,000 people infected with HIV in Burma are not receiving life-saving antiretroviral treatment (ART). This is an improvement on previous years, with new momentum in the country to tackle the crisis,” but the cancellation of the Global Fund to Fight AIDS, Tuberculosis and Malaria Round 11 grants “threatens to undo improvements” and prevent the planned scale-up of ART for an additional 46,500 patients and treatment for another 10,000 tuberculosis (TB) patients.
“On Tuesday the U.S. Positive Women’s Network (PWN) hosted a webinar to discuss HIV-positive women’s sexual rights and to commemorate Valentine’s Day as a day to uphold the rights of HIV-positive women to have safe and satisfying sexual lives,” the Center for Global Health Policy’s “Science Speaks” blog reports. According to the blog, “Presenters discussed various ways in which HIV-positive women can gain sexual and reproductive rights, from using a human rights-based approach, to implementing new biomedical prevention technologies through U.S. health care reform, to how to advocate for women-centered care” (Aziz, 2/16).
“A stakeholder consultation convened by the World Health Organization (WHO) in Geneva has reviewed recent epidemiological studies related to HIV transmission and acquisition by women using hormonal contraceptives,” a UNAIDS press statement reports (2/16). In a technical statement (.pdf), “[t]he Geneva-based United Nations health agency confirmed its existing recommendations [Thursday] after a study published last year found using contraceptive injections doubles the chance women will catch HIV and transmit it to a male partner,” Bloomberg Businessweek reports (Hallam, 2/16). The WHO “concluded that hormonal contraception — whether the pill or injection — was safe for women at risk of HIV to use if they wanted to prevent pregnancy,” the Guardian notes (Boseley, 2/16).